These data highlight that, although the percentage of CD4+ T cells in the tumor is low and express high levels of ICs, these cells could be efficiently reactivated ex vivo and produce high levels of proinflammatory cytokines: this evidence suggests an antitumor role of CD4+ T cells in GBM microenvironment. The gene discussed is CD4; the disease is neoplasm.